Substrate affinity

In non-competitive inhibition, the substrate (S) and inhibitor (I) have equal potential to bind to the free enzyme (E). The inhibitor forms a ternary complex with enzyme-substrate (ES) whereas the substrate will form another ternary complex with enzyme-inhibitor (El). Since the non-competitive inhibitor had no effect on the binding of substrate to the enzyme, the Km value remained consistent (or unchanged). There are two different ways for the formation of ESI ternary complex this complex would not form the product and therefore was decreased. Non-competitive inhibitor had no effect on substrate binding or the enzyme-substrate affinity, therefore the apparent rate constant (K ) was unchanged.5 A possible reason for product inhibition was because of the nature of 2-ethoxyethanol,... 

Important inherent characteristics of an enzyme that should be considered are the substrate affinity, characterized by the Michaelis constant the rate of turnover fecat> providing the catalytic efficiency fecat/ M. and the catalytic potential. Several attempts to compare enzyme catalysis with that of platinum have been published. Direct comparisons are difficult, because enzyme electrodes must be operated in aqueous electrolyte containing dissolved substrate, whereas precious metal electrodes aie often supplied with a humidified gaseous stream of fuel or oxidant, and produce water as steam. It is not straightforward to compare tme optimal turnover rates per active site, as it is often unclear how many active sites are being engaged in a film of enzyme on an electrode. 

The diagnosis of PK deficiency depends on the determination of quantitative enzyme activity or qualitative abnormalities of the enzyme. In 1979, the International Committee for Standardization in Haematology (ICSH) established methods for the biochemical characterization of red blood cell PK variants (M22). Since the establishment of these methods, many PK-deficient cases have been characterized, including 13 cases of homozygous PK deficiency. Residual red blood cell PK activity is not usually associated with phenotypic severity,whereas enzymatic characteristics such as decreased substrate affinity, thermal instability, or impaired response to the allosteric activator fructose-1,6-diphosphate (F-1,6-DP) correspond to a more severe phenotype. 

Electrophoretic and kinetic studies of the patient s enzyme have been reported in several cases (F10). Most of them showed decreased substrate affinity and abnormal electrophoretic mobility. The main cause of P5N deficiency is considered to be an abnormality of P5N-I, probably arising from a structural gene mutation (H6). The precise molecular defect has not been clarified, because the normal gene for P5N-I has not been isolated. 

K7. Kanno, H Fujii, H and Miwa, S., Low substrate affinity of pyruvate kinase variant (PK Sapporo) due to a single amino acid substitution (426Arg- Gln) associated with hereditary hemolytic anemia. Blood 81,2439-2441 (1993). 

An inhibitor that binds exclusively to the ES complex, or a subsequent species, with little or no affinity for the free enzyme is referred to as uncompetitive. Inhibitors of this modality require the prior formation of the ES complex for binding and inhibition. Hence these inhibitors affect the steps in catalysis subsequent to initial substrate binding that is, they affect the ES —> ES1 step. One might then expect that these inhibitors would exclusively affect the apparent value of Vm and not influence the value of KM. This, however, is incorrect. Recall, as illustrated in Figure 3.1, that the formation of the ESI ternary complex represents a thermodynamic cycle between the ES, El, and ESI states. Hence the augmentation of the affinity of an uncompetitive inhibitor that accompanies ES complex formation must be balanced by an equal augmentation of substrate affinity for the El complex. The result of this is that the apparent values of both Vmax and Ku decrease with increasing concentrations of an uncompetitive inhibitor (Table 3.3). The velocity equation for uncompetitive inhibition is as follows ... 

There are different types of cholinesterases in the human body, and they differ in their location in tissues, substrate affinity, and physiological function. The main ones are ACHE, present in nervous tissue and red blood cells (RBC-ACHE), and plasma cholinesterases (PCHE), present in glial cells, plasma, and liver. The physiological functions of RBC-ACHE and PCHE, if any, are unknown. 

Hemoglobin is another heme-containing protein, which has been shown to be active towards PAH, oxidation in presence of peroxide [420], This protein was also modified via PEG and methyl esterification to obtain a more hydrophobic protein with altered activity and substrate specificity. The modified protein had four times the catalytic efficiency than that of the unmodified protein for pyrene oxidation. Several PAHs were also oxidized including acenaphthene, anthracene, azulene, benzo(a)pyrene, fluoranthene, fluorene, and phenanthrene however, no reaction was observed with chrysene and biphenyl. Modification of hemoglobin with p-nitrophenol and p-aminophenol has also been reported [425], The modification was reported to enhance the substrate affinity up to 30 times. Additionally, the solvent concentration at which the enzyme showed maximum activity was also higher. Both the effects were attributed to the increase in hydrophobicity of the active site. 

Each enzyme has a working name, a specific name in relation to the enzyme action and a code of four numbers the first indicates the type of catalysed reaction the second and third, the sub- and sub-subclass of reaction and the fourth indentifies the enzyme [18]. In all relevant studies, it is necessary to state the source of the enzyme, the physical state of drying (lyophilized or air-dried), the purity and the catalytic activity. The main parameter, from an analytical viewpoint is the catalytic activity which is expressed in the enzyme Unit (U) or in katal. One U corresponds to the amount of enzyme that catalyzes the conversion of one micromole of substrate per minute whereas one katal (SI unit) is the amount of enzyme that converts 1 mole of substrate per second. The activity of the enzyme toward a specific reaction is evaluated by the rate of the catalytic reaction using the Michaelis-Menten equation V0 = Vmax[S]/([S] + kM) where V0 is the initial rate of the reaction, defined as the activity Vmax is the maximum rate, [S] the concentration of substrate and KM the Michaelis constant which give the relative enzyme-substrate affinity. 

Alexander, S., Gorboulev, V., Gorbunov, D., Kelley T., Volk, C., Schmitt, B.M., Schlachtbauer, P., Ciarimboli, G., and Koepsell, H. (2007) Identification of cysteines in rat organic cation transporters rOCTl (C322,C451) and rOCT2 (C451) critical for transport activity and substrate affinity. Am. J. Physiol. Renal Physiol, (web preprint, June 13, 2007). 

The MWC model says that in the R state, all the active sites are the same and all have higher substrate affinity than in the T state. If one site is in the R state, all are. In any one protein molecule at any one time, all subunits are supposed to have identical affinities for substrate. Because the transition between the R and the T states happens at the same time to all subunits, the MWC model has been called file concerted model for allosterism and cooperativity. The MWC model invokes this symmetry principle because the modelers saw no compelling reason to think that one of the chemically identical subunits of a protein would have a conformation that was different from the others. Alternative models exist that suggest that each subunit can have a different conformation and different affinities for substrate. Experimentally, examples are known that follow each model. 

Figure 2. Schematic visualisation of how increased specific substrate affinity resulting in lowered cell surface substrate concentration (a) and closer approach to a substrate source, e.g. by attachment to the substrate (b) steepens concentration gradients and thereby increases the diffusion flux from a distant substrate source (c

Because of its prominent appearance in the whole cell Michaelis-Menten equation, Kt is frequently mistaken as a measure of the substrate affinity. However, from equations (2) and (4), it becomes obvious that the activity versus concentration relationship is characterised by the two independent parameters, 2max, as a descriptor of the zero-order part at high substrate concentration, and a°A, as a descriptor of the slope of the first-order part of the curve. In his much-cited review paper, Button [9] has listed the specific affinities of various organisms for a range of carbon sources and other elements. Reported variations for the same substrates extend over up to four orders of magnitude. Table 1 updates... 

Dideoxyuridine (ddU) is an antiviral agent that proved ineffective at controlling human immunodeficiency virus type 1 (HIV-1) infection in human T-cells. This ineffectiveness was ascribed to a lack of substrate affinity of ddU for cellular nucleoside kinases, which prevent it from being metabolized to the active 5 -triphosphate. To overcome this problem, bis[(pivaloyloxy)methyl] 2, 3 -dideoxyuridine 5 -monophosphate (9.41) was prepared and shown to be a membrane-permeable prodrug of 2, 3 -di-deoxyuridine 5 -monophosphate (ddUMP, 9.42) [93]. Indeed, human T-cell lines exposed to 9.41 rapidly formed the mono-, di-, and triphosphate of ddU, and antiviral activity was observed. This example again documents... 

The ability of a reversible inhibitor to alter substrate affinity on binding to the enzyme, and vice versa, as well as the ability of the inhibitor to alter fcp, generally occur because of allosteric effects. As the allosteric effects of a molecule are related to its size, shape, and charge distribution, it might be expected that different... 

It is not a requirement that binding of an allosteric modulator to an enzyme must result in inhibition of activity indeed, in some mixed inhibition systems described earlier, both a and P have values between 0 and 1. If an increase in substrate affinity outweighs a decrease in at lower substrate concentrations, an increase in enzyme activity may occur, relative to control values, and the use of the term inhibitor to classify such a compound is open to debate. 

---